These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 28129034

  • 1. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H, Bao Y, Wang X, Zhou D, Wu W.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-9. PubMed ID: 28129034
    [Abstract] [Full Text] [Related]

  • 2. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 3. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 4. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE.
    Vaccine; 2012 Jan 05; 30(2):466-74. PubMed ID: 22051136
    [Abstract] [Full Text] [Related]

  • 5. Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
    Fan X, Su Q, Qiu F, Yi Y, Shen L, Jia Z, Liang P, Zou Y, Bi S.
    Vaccine; 2018 Jul 05; 36(29):4354-4361. PubMed ID: 29880240
    [Abstract] [Full Text] [Related]

  • 6. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
    Proudfoot O, Esparon S, Tang CK, Laurie K, Barr I, Pietersz G.
    BMC Infect Dis; 2015 Feb 26; 15():101. PubMed ID: 25887952
    [Abstract] [Full Text] [Related]

  • 7. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 8. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Mizuno D, Kimoto T, Sakai S, Takahashi E, Kim H, Kido H.
    Vaccine; 2016 Apr 07; 34(16):1881-8. PubMed ID: 26954466
    [Abstract] [Full Text] [Related]

  • 9. Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.
    Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, Baker JR, Kawaoka Y.
    Vaccine; 2012 Nov 06; 30(48):6871-7. PubMed ID: 22989689
    [Abstract] [Full Text] [Related]

  • 10. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M, Aqrawi LA, Zhou F, Pedersen G, Trieu MC, Zhou P, Cox RJ.
    Scand J Immunol; 2015 May 06; 81(5):305-17. PubMed ID: 25737202
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 06; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 12. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T, Ainai A, Nakamura T, Akiyama Y, Maeyama J, Odagiri T, Tashiro M, Takahashi H, Sawa H, Tamura S, Chiba J, Kurata T, Sata T, Hasegawa H.
    J Med Virol; 2010 Jan 06; 82(1):128-37. PubMed ID: 19950232
    [Abstract] [Full Text] [Related]

  • 13. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK, Stittelaar KJ, Veldhuis Kroeze EJ, van Amerongen G, Dijkshoorn ML, Krestin GP, Hinkula J, Arwidsson H, Lindberg A, Osterhaus AD.
    Vaccine; 2014 May 30; 32(26):3307-15. PubMed ID: 24690149
    [Abstract] [Full Text] [Related]

  • 14. [Chitosan as an adjuvant for parenteral inactivated influenza vaccines].
    Gendon IuZ, Markushin SG, Krivtsov GG, Akopova II.
    Vopr Virusol; 2008 May 30; 53(5):14-9. PubMed ID: 19069787
    [Abstract] [Full Text] [Related]

  • 15. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura J Renukaradhya, Li F, Francis DH, Kaushik RS, Khatri M.
    Vaccine; 2015 Jan 15; 33(4):542-8. PubMed ID: 25437101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.
    Okamoto S, Matsuoka S, Takenaka N, Haredy AM, Tanimoto T, Gomi Y, Ishikawa T, Akagi T, Akashi M, Okuno Y, Mori Y, Yamanishi K.
    Clin Vaccine Immunol; 2012 Jul 15; 19(7):979-90. PubMed ID: 22552600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S, Renu S, Ghimire S, Shaan Lakshmanappa Y, Hogshead BT, Feliciano-Ruiz N, Lu F, HogenEsch H, Krakowka S, Lee CW, Renukaradhya GJ.
    Front Immunol; 2018 Jul 15; 9():934. PubMed ID: 29770135
    [Abstract] [Full Text] [Related]

  • 20. Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection.
    Li Y, Xu YL, Lai YN, Liao SH, Liu N, Xu PP.
    Phytomedicine; 2017 Oct 15; 34():127-135. PubMed ID: 28899494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.